Results 221 to 230 of about 39,721 (242)

Nevirapine

Reactions Weekly, 1998
openaire   +1 more source

Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial

Lancet, The, 2004
Christian Laurent, Florian Liegeois, Eric Delaporte   +2 more
exaly  

Nevirapine

Reactions Weekly, 2004
openaire   +1 more source

Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials

Lancet, The, 2008
Ben J Marais, Jayagowri Sastry, Nishi Suryavanshi   +2 more
exaly  

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial

Lancet, The, 2003
J Brooks Jackson, Danstan Bagenda, Paul M Bakaki   +2 more
exaly  

Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial

Lancet, The, 2007
Benjamin H Chi, Jeffrey S A Stringer
exaly  

Nevirapine

Reactions Weekly, 2016
openaire   +2 more sources

Zambian women's attitudes toward mass nevirapine therapy to prevent perinatal transmission of HIV

Lancet, The, 2001
Julia P Stout
exaly  

HLA-allelotype associations with nevirapine-induced hypersensitivity reactions and hepatotoxicity: a systematic review of the literature and meta-analysis

Pharmacogenetics & Genomics, 2015
Elena M. Cornejo Castro, D. Carr, A. Jorgensen, A. Alfirevic, M. Pirmohamed   +4 more
semanticscholar   +1 more source

Nevirapine

Reactions Weekly, 2013
openaire   +2 more sources